UC San Diego’s Natasha Martin awarded $5.6M NIDA Avant-Garde Award to prevent HIV, hepatitis C, and overdose

NCI renews the UC San Diego Moores CCSG, committing $25M

University of California San Diego Moores Cancer Center has received a five-year, $25 million Cancer Center Support Grant from NCI.

June 18, 2026

Vol.52 No.24

Clinical Roundup

AI model links tumor mutations to treatment response, UCSD study finds

An artificial intelligence model may be able to translate a tumor’s complex genetic profile into predictions about how that cancer may respond to treatment, according to a study conducted by researchers at University of California San Diego.

May 29, 2026

Vol.52 No.21

Clinical Roundup

Immunity against CMV leveraged against pancreatic cancer in study by UCSD, La Jolla Institute of Immunology

Researchers at the University of California San Diego and La Jolla Institute of Immunology have discovered a promising treatment approach for pancreatic cancer, one of the deadliest and most treatment-resistant forms of cancer. The approach leverages the body’s natural immune response to cytomegalovirus, a common but typically harmless virus that most people are infected with at some point in their lives.

February 13, 2026

Vol.52 No.06

Clinical Roundup

UCSD researchers engineer novel antibody that triggers anti-tumor response

Researchers at the UC San Diego School of Medicine engineered a new anti-αvβ3 antibody that activates macrophages—a type of immune cell already abundant in advanced αvβ3+ tumors—and were able to trigger anti-tumor responses in both patient tumor samples and in mouse models.

October 17, 2025

Vol.51 No.38

Clinical Roundup

Checkpoint therapy breakthrough sparks new vaccine

Immune-checkpoint therapy, which attempts to harness a patient’s own immune system to fight cancer, has revolutionized cancer care over the past two decades.

September 12, 2025

Vol.51 No.33

Clinical Roundup

Cannabis use disorder triples risk of oral cancer, UCSD study finds

Individuals with cannabis use disorder are more than three times more likely to develop oral cancer within five years compared to those without CUD, a researcher at the University of California San Diego School of Medicine found.

August 01, 2025

Vol.51 No.30

UC San Diego’s Natasha Martin awarded $5.6M NIDA Avant-Garde Award to prevent HIV, hepatitis C, and overdose

YOU MAY BE INTERESTED IN

NCI renews the UC San Diego Moores CCSG, committing $25M

AI model links tumor mutations to treatment response, UCSD study finds

Immunity against CMV leveraged against pancreatic cancer in study by UCSD, La Jolla Institute of Immunology

UCSD researchers engineer novel antibody that triggers anti-tumor response

Checkpoint therapy breakthrough sparks new vaccine

Cannabis use disorder triples risk of oral cancer, UCSD study finds

Renew today!

Subscriber content

Never miss an issue!

Login